158 related articles for article (PubMed ID: 26797414)
21. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro.
Fan YZ; Fu JY; Zhao ZM; Chen CQ
Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):72-80. PubMed ID: 17287171
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-146b-5p inhibits the growth of gallbladder carcinoma by targeting epidermal growth factor receptor.
Cai J; Xu L; Cai Z; Wang J; Zhou B; Hu H
Mol Med Rep; 2015 Jul; 12(1):1549-55. PubMed ID: 25760482
[TBL] [Abstract][Full Text] [Related]
23. Shikonin induces apoptosis and G0/G1 phase arrest of gallbladder cancer cells via the JNK signaling pathway.
Zhai T; Hei Z; Ma Q; Liang H; Xu Y; Zhang Y; Jin L; Han C; Wang J
Oncol Rep; 2017 Dec; 38(6):3473-3480. PubMed ID: 29039581
[TBL] [Abstract][Full Text] [Related]
24. Influence of norcantharidin on proliferation, proliferation-related gene proteins proliferating cell nuclear antigen and Ki-67 of human gallbladder carcinoma GBC-SD cells.
Fan YZ; Fu JY; Zhao ZM; Chen CQ
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):603-7. PubMed ID: 15567755
[TBL] [Abstract][Full Text] [Related]
25. Baicalein inhibits progression of gallbladder cancer cells by downregulating ZFX.
Liu TY; Gong W; Tan ZJ; Lu W; Wu XS; Weng H; Ding Q; Shu YJ; Bao RF; Cao Y; Wang XA; Zhang F; Li HF; Xiang SS; Jiang L; Hu YP; Mu JS; Li ML; Wu WG; Shen BY; Jiang LX; Liu YB
PLoS One; 2015; 10(1):e0114851. PubMed ID: 25617627
[TBL] [Abstract][Full Text] [Related]
26. Galectin-9 Induces Mitochondria-Mediated Apoptosis of Esophageal Cancer In Vitro and In Vivo in a Xenograft Mouse Model.
Chiyo T; Fujita K; Iwama H; Fujihara S; Tadokoro T; Ohura K; Matsui T; Goda Y; Kobayashi N; Nishiyama N; Yachida T; Morishita A; Kobara H; Mori H; Niki T; Hirashima M; Himoto T; Masaki T
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31146370
[TBL] [Abstract][Full Text] [Related]
27. [The role of tissue factor pathway inhibitor-2 gene in gallbladder cancer].
Qin YY; Gong W; Weng MZ; Li JY; Quan ZW
Zhonghua Wai Ke Za Zhi; 2012 Dec; 50(12):1099-103. PubMed ID: 23336488
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-26a acts as a tumor suppressor inhibiting gallbladder cancer cell proliferation by directly targeting HMGA2.
Zhou H; Guo W; Zhao Y; Wang Y; Zha R; Ding J; Liang L; Hu J; Shen H; Chen Z; Yin B; Ma B
Int J Oncol; 2014 Jun; 44(6):2050-8. PubMed ID: 24682444
[TBL] [Abstract][Full Text] [Related]
29. Loss of angiotensin-converting enzyme 2 promotes growth of gallbladder cancer.
Zong H; Yin B; Zhou H; Cai D; Ma B; Xiang Y
Tumour Biol; 2015 Jul; 36(7):5171-7. PubMed ID: 25663464
[TBL] [Abstract][Full Text] [Related]
30. Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor.
Lee HJ; Lee K; Lee DG; Bae KH; Kim JS; Liang ZL; Huang SM; Suk Oh Y; Kim HY; Jo DY; Min JK; Kim JM; Lee HJ
Clin Cancer Res; 2012 Jun; 18(12):3270-80. PubMed ID: 22553346
[TBL] [Abstract][Full Text] [Related]
31. The cell adhesion molecule L1 promotes gallbladder carcinoma progression in vitro and in vivo.
Jung J; Son YS; Park H; Jeon SK; Lee JW; Choi SY; Kim JM; Kwon YG; Hong HJ; Min JK
Oncol Rep; 2011 Apr; 25(4):945-52. PubMed ID: 21318226
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of stathmin 1 in human gallbladder carcinoma inhibits tumor growth in vitro and in vivo.
Wang J; Yao Y; Ming Y; Shen S; Wu N; Liu J; Liu H; Suo T; Pan H; Zhang D; Ding K; Liu H
Sci Rep; 2016 Jun; 6():28833. PubMed ID: 27349455
[TBL] [Abstract][Full Text] [Related]
33. Contribution of the PI3K/MMPs/Ln-5γ2 and EphA2/FAK/Paxillin signaling pathways to tumor growth and vasculogenic mimicry of gallbladder carcinomas.
Lu XS; Sun W; Ge CY; Zhang WZ; Fan YZ
Int J Oncol; 2013 Jun; 42(6):2103-15. PubMed ID: 23588386
[TBL] [Abstract][Full Text] [Related]
34. Effects of oxymatrine on the apoptosis and proliferation of gallbladder cancer cells.
Wu XS; Yang T; Gu J; Li ML; Wu WG; Weng H; Ding Q; Mu JS; Bao RF; Shu YJ; Cao Y; Wang XA; Ding QC; Dong P; Xie SF; Liu YB
Anticancer Drugs; 2014 Oct; 25(9):1007-15. PubMed ID: 24869760
[TBL] [Abstract][Full Text] [Related]
35. Fibronectin promotes cell proliferation and invasion through mTOR signaling pathway activation in gallbladder cancer.
Cao Y; Liu X; Lu W; Chen Y; Wu X; Li M; Wang XA; Zhang F; Jiang L; Zhang Y; Hu Y; Xiang S; Shu Y; Bao R; Li H; Wu W; Weng H; Yen Y; Liu Y
Cancer Lett; 2015 May; 360(2):141-50. PubMed ID: 25657110
[TBL] [Abstract][Full Text] [Related]
36. Bcl-2 gene silencing by RNA interference inhibits the growth of the human gallbladder carcinoma cell line GBC-SD in vitro and in vivo.
Geng ZM; Zhang M; Pan XT; Wang L
Oncol Rep; 2013 Aug; 30(2):793-800. PubMed ID: 23784204
[TBL] [Abstract][Full Text] [Related]
37. Tea polyphenols induce S phase arrest and apoptosis in gallbladder cancer cells.
Wang J; Pan Y; Hu J; Ma Q; Xu Y; Zhang Y; Zhang F; Liu Y
Braz J Med Biol Res; 2018 Mar; 51(4):e6891. PubMed ID: 29513793
[TBL] [Abstract][Full Text] [Related]
38. PTEN deficiency facilitates the therapeutic vulnerability to proteasome inhibitor bortezomib in gallbladder cancer.
Jiang TY; Feng XF; Fang Z; Cui XW; Lin YK; Pan YF; Yang C; Ding ZW; Zhang YJ; Tan YX; Wang HY; Dong LW
Cancer Lett; 2021 Mar; 501():187-199. PubMed ID: 33220333
[TBL] [Abstract][Full Text] [Related]
39. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
[TBL] [Abstract][Full Text] [Related]
40. MYBL2 is a Potential Prognostic Marker that Promotes Cell Proliferation in Gallbladder Cancer.
Liang HB; Cao Y; Ma Q; Shu YJ; Wang Z; Zhang F; Ye YY; Li HF; Xiang SS; Song XL; Xu Y; Zhang YC; Bao RF; Yuan RY; Zhang YJ; Hu YP; Jiang L; Li ML; Wang XA; Wu XS; Wu WG; Zhao S; Fand Y; Cui XP; Lu YS; Zhou J; Zheng L; Gong W; Liu YB
Cell Physiol Biochem; 2017; 41(5):2117-2131. PubMed ID: 28427077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
